<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>Aethlon Medical, Inc.</title>
<link>http://aethlonmedical.investorroom.com/</link>
<description>Aethlon Medical, Inc.</description>
<item>
<title>Aethlon Medical (AEMD) Note: An Update on the Clinical Status of the Aethlon Hemopurifier® in Hepatitis-C Care</title>
<link>http://aethlonmedical.investorroom.com/2013-05-07-Aethlon-Medical-AEMD-Note-An-Update-on-the-Clinical-Status-of-the-Aethlon-Hemopurifier-in-Hepatitis-C-Care</link>
<description></description>
<pubDate>Tue, 07 May 2013 16:01:00 -0400</pubDate>
<guid>http://aethlonmedical.investorroom.com/2013-05-07-Aethlon-Medical-AEMD-Note-An-Update-on-the-Clinical-Status-of-the-Aethlon-Hemopurifier-in-Hepatitis-C-Care</guid>
</item>
<item>
<title>Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013</title>
<link>http://aethlonmedical.investorroom.com/2013-04-18-Aethlon-Medical-Discloses-Cancer-and-Infectious-Disease-Therapy-Presentation-at-ISEV-2013</link>
<description></description>
<pubDate>Thu, 18 Apr 2013 09:30:00 -0400</pubDate>
<guid>http://aethlonmedical.investorroom.com/2013-04-18-Aethlon-Medical-Discloses-Cancer-and-Infectious-Disease-Therapy-Presentation-at-ISEV-2013</guid>
</item>
<item>
<title>Aethlon Medical (AEMD) Note:  New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President Obama</title>
<link>http://aethlonmedical.investorroom.com/2013-04-16-Aethlon-Medical-AEMD-Note-New-Government-Contract-Resubmission-of-IDE-to-Treat-Hepatitis-C-HCV-Biothreat-Legislation-Signed-into-Law-by-President-Obama</link>
<description></description>
<pubDate>Tue, 16 Apr 2013 09:30:00 -0400</pubDate>
<guid>http://aethlonmedical.investorroom.com/2013-04-16-Aethlon-Medical-AEMD-Note-New-Government-Contract-Resubmission-of-IDE-to-Treat-Hepatitis-C-HCV-Biothreat-Legislation-Signed-into-Law-by-President-Obama</guid>
</item>
<item>
<title>Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease &amp; Cancer</title>
<link>http://aethlonmedical.investorroom.com/2013-02-28-Aethlon-Medical-AEMD-Note-Multiple-Shots-on-Goal-A-Therapeutic-Strategy-to-Address-Infectious-Disease-Cancer</link>
<description></description>
<pubDate>Thu, 28 Feb 2013 09:25:00 -0500</pubDate>
<guid>http://aethlonmedical.investorroom.com/2013-02-28-Aethlon-Medical-AEMD-Note-Multiple-Shots-on-Goal-A-Therapeutic-Strategy-to-Address-Infectious-Disease-Cancer</guid>
</item>
<item>
<title>Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com</title>
<link>http://aethlonmedical.investorroom.com/2013-02-11-Aethlon-Medical-Inc.-Investor-Presentation-Now-Available-for-On-demand-Viewing-at-RetailInvestorConferences.com</link>
<description>Company invites individual and institutional investors to log-on to view presentation</description>
<pubDate>Mon, 11 Feb 2013 07:00:00 -0500</pubDate>
<guid>http://aethlonmedical.investorroom.com/2013-02-11-Aethlon-Medical-Inc.-Investor-Presentation-Now-Available-for-On-demand-Viewing-at-RetailInvestorConferences.com</guid>
</item>
</channel>
</rss>
